Loading chat...

IN SB0069

Bill

Status

Introduced

1/3/2017

Primary Sponsor

Jean Breaux

Click for details

Origin

Senate

2017 Regular Session

AI Summary

  • Legislative council is urged to assign an interim study committee to examine prescription drug pricing and access to specialty prescription drugs during the 2017 interim period
  • Study committee shall examine other states' actions to lower prescription drug prices, including limits on out-of-pocket costs for health plan insureds and enrollees
  • Committee must report recommendations to the legislative council in electronic format no later than November 1, 2017
  • This section expires December 31, 2017
  • Emergency declaration included for the act

Legislative Description

Study of drug pricing and access. Urges the legislative council to assign to an interim study committee a study of prescription drug pricing and access to specialty prescription drugs. Requires submission of a report and recommendations to the legislative council.

Last Action

First reading: referred to Committee on Health and Provider Services

1/3/2017

Committee Referrals

Health and Provider Services1/3/2017

Full Bill Text

No bill text available